Invesco Biotechnology & Genome ETF

PBEAMEX · USD
94.91USD0.00 (-0.80%)

Invesco Biotechnology & Genome ETF (PBE) Wheel Strategy

PBE wheel strategy scan found 23 cash-secured put setups on the previous trading day. Probability of expiring worthless is above 50%. Annualized returns reach up to 30.5%.

Read more

Running a PBE wheel strategy lets you generate consistent premium income on Invesco Biotechnology & Genome ETF while setting your own entry and exit prices on the underlying. Invesco Biotechnology & Genome ETF's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own PBE, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best PBE wheel strategy setups in real time.

The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on PBE, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable PBE wheel from a losing one.

The Invesco Biotechnology & Genome ETF (Fund) is based on the Dynamic Biotech & Genome Intellidex Index (Index). The Fund will normally invest at least 90% of its total assets in the securities that comprise the Index. The Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Index is comprised of securities of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances in biotechnology and genetic engineering and research.

The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.

The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the PBE wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your PBE wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.

Oct 16, 202695.00$0.30$2.30-0.432911%55.3%30.5%0
Nov 20, 202695.00$1.00$3.50-0.436411%54.2%21.0%0
Nov 20, 202694.00$0.70$3.20-0.396411%58.7%19.4%0
Nov 20, 202693.00$0.50$3.00-0.366411%63.1%18.4%0
Dec 18, 202695.00$1.60$4.10-0.429211%53.9%17.1%0
Dec 18, 202693.00$0.80$3.30-0.369211%61.4%14.1%0
Dec 18, 202692.00$0.60$3.10-0.339211%65.1%13.4%0
Dec 18, 202691.00$0.40$2.90-0.319211%68.7%12.6%0
Mar 19, 202796.00$3.30$5.80-0.4318311%51.1%12.1%0
Dec 18, 202687.00$0.80$2.55-0.249211%81.4%11.6%0

As of September 18, 2026

Run the Wheel on PBE With Confidence

Find the best PBE wheel strategy setups across strikes and expirations, plan ahead with at-strike values, and keep your covered calls and puts on track.

Start your 14-day free trial